Documente Academic
Documente Profesional
Documente Cultură
NEURALGIA
Introduction
Definition
Tic douloureux
Aetiology
Pathogenesis
General characteristics
Clinical characteristics
Diagnosis
Treatment modalities
Management
INTRODUCTION:
Incidence: 8 : 1,00,000
Division of trigeminal
nerve involvement: V3 > V2 > V1
CLINICAL CHARACTERISTICS:
Manifests as a sudden, unilateral, intermittent
paroxysmal, sharp, shooting, lancinating, shock like
pain, elicited by slight touching superficial ‘trigger
points’ which radiates from that point, across the
distribution of one or more branches of the
trigeminal nerve.
Cutaneous Intraoral
Corner of the lips Teeth
Cheek Gingivae
Ala of the nose Tongue
Lateral brow
DIAGNOSIS:
MEDICAL SURGICAL
MEDICAL MANAGEMENT:
It is the first line approach for most of the patients.
CARBAMAZEPINE:
Trade name: Tegretol
Carbitrol
Dosage: 100 – 2000 mg/day
Side effects: visual blurring
dizziness
skin rashes
rarely hepatic dysfunction, leukemia,
thrombocytopenia, aplastic anemia
PHENYTOIN:
It is a GABA agonists.
These drugs reduces the central projection painful
afferent impulses.
Disadvantage:
May produce
full anaesthesia
deep hypoesthesia
INFRAORBITAL NEURECTOMY:
PERCUTANEOUS RHIZOTOMY:
Technique:
Toxicity of drugs
Failure of response to the other modalities
Dependence on the drugs for life time.
Elderly patients
Medically compromised patients
Advantages:
Simple technique
Lower incidence
of anaesthesia
dolorosa
Complication:
Technique:
A no. 4 Fogarthy’s catheter is introduced with
fluoroscopic guidance.
A 0.7 mm balloon is inflated for 1 – 2 minutes.
OPEN PROCEDURES ( INTRACRANIAL
PROCEDURES):